Dec Nov 2008 Journal of veterinary internal medicine

Masitinib is safe and effective for the treatment of canine mast cell tumors.

Auteurs

Hahn KA, Ogilvie G, Oglivie G, Rusk T, Devauchelle P, Legendre A, Powers B, Leventhal PS, Kinet JP, Palmerini F, Dubreuil P, Moussy A, Hermine O

Résumé

Activation of the KIT receptor tyrosine kinase is associated with the development of canine mast cell tumors (MCT).

Lire l‘article